M&A Deal Summary |
|
|---|---|
| Date | 2024-01-01 |
| Target | Hovione |
| Sector | Life Science |
| Buyer(s) | Explorer Investments |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 1.8B EUR |
| Size | Large |
| Type | Sector Agnostic |
Explorer Investments is a private investment firm that looks to fund buyouts, as well as provide expansion and replacement capital to middle-market Portuguese companies. Explorer looks to invest a minimum of €10 million in transactions valued up to €150 million. Explorer does not have any sector preferences and typically holds investments for three to six years. Explorer Investments was formed in 2003 and is based in Lisbon, Portugal.
| DEAL STATS | # |
|---|---|
| Overall | 67 of 73 |
| Sector: Life Science M&A | 6 of 8 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 36 of 40 |
| Country: Portugal M&A | 63 of 68 |
| Year: 2024 M&A | 2 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-01 |
BBG Aluminium Systems
Braga, Portugal BBG Aluminium Systems manufactures and assembles a multitude of metallic products such as metal structures, railings, and guardrails, doors, windows, fixed and ventilated glass curtain walls. BBG Aluminium Systems was founded in 2008 and is based in Braga, Portugal. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-11 |
Lxbio Pharmaceuticals
Lisbon, Portugal Lxbio Pharmaceuticals is a biotech company specialising in advanced biologic therapies such as bacteriophage treatments, monoclonal antibodies, CAR-T cells and innovative drug delivery systems. It focuses on developing solutions for difficult-to-treat infections, oncology and immune-related diseases. Lxbio Pharmaceuticals is based in Lisbon, Portugal. |
Buy | - |
